Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Syndax sets terms for a $69M IPO to support its 'breakthrough' drug
Syndax sets terms for a $69M IPO to support its 'breakthrough' drug
Syndax sets terms for a $69M IPO to support its 'breakthrough' drug
Submitted by
admin
on June 5, 2014 - 12:17pm
Source:
Fierce Biotech
News Tags:
Syndax Pharma
IPOs
breast cancer
breakthrough therapies
entinostat
Headline:
Syndax sets terms for a $69M IPO to support its 'breakthrough' drug
Do Not Allow Advertisers to Use My Personal information
